GlassScriptPhysician profile
Lisa Havick
NPI 1063878288
$331.50
in general payments reported to CMS, 2019-2025
8 companies · $20.27 in 2025
The $20.27 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14.82 · 2023: $131 · 2024: $165 · 2025: $20.27.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $316.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioxcel Therapeutics, INC. | $124.68 | 2024 | Igalmi |
| Shionogi INC | $57.12 | 2023-2024 | Fetroja |
| Csl Behring | $41.82 | 2023 | Kcentra |
| Aroa Biosurgery Incorporated | $31.16 | 2023 | |
| Alafair Biosciences, INC. | $25.39 | 2024 | Versawrap |
| Acera Surgical, INC. | $20.27 | 2025 | Restrata Wound Matrix |
| Merck Sharp & Dohme LLC | $16.24 | 2023 | Dificid, Zerbaxa, Recarbrio |
| Medtronic, INC. | $14.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Havick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.